Aralez Pharmaceuticals Inc. (TSE:ARZ)’s share price was down 0.5% during mid-day trading on Monday . The stock traded as low as C$1.91 and last traded at C$1.95. Approximately 34,972 shares were traded during mid-day trading, a decline of 18% from the average daily volume of 42,757 shares. The stock had previously closed at C$1.94.

ILLEGAL ACTIVITY NOTICE: “Aralez Pharmaceuticals (ARZ) Trading Down 0.5%” was published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at https://theolympiareport.com/2017/12/06/aralez-pharmaceuticals-arz-trading-down-0-5.html.

Aralez Pharmaceuticals Company Profile

Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.

Receive News & Ratings for Aralez Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.